Oct 26 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2020 Sep 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.09 2.28 4.50
(-8.4 pct) (+1.0 pct) (-2.4 pct)
Operating 320 mln 321 mln 650 mln
(-0.2 pct) (+4.7 pct) (+6.8 pct)
Recurring 325 mln 321 mln 650 mln
(+1.4 pct) (-1.1 pct) (+5.5 pct)
Net 200 mln 221 mln 450 mln
(-9.2 pct) (+0.7 pct) (+12.9 pct)
EPS 48.06 yen 54.76 yen 107.61 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T